Trials that use: Covariate adjustment
5,848 results
- SPEEDIndependent statistical analysis of Patient Actor Training to Improve HIV Services for Adolescents in Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPEEDIndependent statistical analysis of Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery: Complete Statistical AnalysisIndependent statistical analysis of Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SPGblockIndependent statistical analysis of Sphenopalatine Ganglion Blocks RCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03666663).
- Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines: Complete Statistical AnalysisIndependent statistical analysis of Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPIN-CHATIndependent statistical analysis of Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Spinal Plasticity to Enhance Motor Retraining After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Spinal Plasticity to Enhance Motor Retraining After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03645122).
- SPINSIndependent statistical analysis of Stress CMR Perfusion Imaging in the United States (SPINS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03192891).
- Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®): Complete Statistical AnalysisIndependent statistical analysis of Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SPIRE-1An independent statistical analysis of SPIRE-1 (NCT01975376), the terminated phase 3 placebo-controlled trial of bococizumab for prevention of major cardiovascular events: stratified Cox hazard ratios, MMRM and ANCOVA lipid analyses, multiplicity and…
- SPIRE-1Independent statistical analysis of The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPIRE-2Independent statistical analysis of SPIRE-2 (NCT01975389), the terminated phase 3 placebo-controlled trial of bococizumab in high-risk participants: stratified Cox hazard ratios for major cardiovascular events, MMRM and ANCOVA lipid analyses, and serious…
- SPIRE-2Independent statistical analysis of The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SPIRE-HRIndependent statistical analysis of Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events: primary endpoint results, effect estimate with confidence interval, sample-size…
- SPIRITIndependent statistical analysis of A Representational Intervention to Promote Preparation for End-of-life Decision Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01259011).
- SPIRITIndependent statistical analysis of Antiarrhythmic Effects of Spironolactone in Patients With ICDs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495712).
- SPIRITIndependent statistical analysis of Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00244842).
- SPIRITIndependent statistical analysis of Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study): Complete Statistical AnalysisIndependent statistical analysis of SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study): primary…
- SPIRITT – Second-Line Panitumumab Irinotecan Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418938).
- Spironolactone in Adult Congenital Heart Disease: Complete Statistical AnalysisIndependent statistical analysis of Spironolactone in Adult Congenital Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01069510).
- SPLASHIndependent statistical analysis of A Multi-Component Alcohol and Sex Risk Intervention for College Students: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05180539).
- SPLDIndependent statistical analysis of Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SPPIndependent statistical analysis of Supporting Parents Program: Intervention for Families in CPS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01332851).
- SPREADIndependent statistical analysis of Sleep to Prevent Evolving Affecting Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02988375).
- SPREAD-NETIndependent statistical analysis of SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02325531).
- Sprifermin (AS902330) in Cartilage Injury Repair (CIR): Complete Statistical AnalysisIndependent statistical analysis of Sprifermin (AS902330) in Cartilage Injury Repair (CIR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01066871).
- SPRING-2Independent statistical analysis of A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPT for Sensitization of Collagen Dressing: Complete Statistical AnalysisIndependent statistical analysis of SPT for Sensitization of Collagen Dressing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06271993).
- SQ53 Disinfectant Wipes for Prevention of CRBSI: Complete Statistical AnalysisIndependent statistical analysis of SQ53 Disinfectant Wipes for Prevention of CRBSI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04822467).
- SR-WBV Training for Frail Elderly in the Skilling up Stage: Complete Statistical AnalysisIndependent statistical analysis of SR-WBV Training for Frail Elderly in the Skilling up Stage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01704976).
- SSWIndependent statistical analysis of Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers Phase I: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- STABIL-BIndependent statistical analysis of Sequential Therapy for the Treatment of Severe Bipolar Depression.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02974010).
- Staccato Loxapine in Agitated Patients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Staccato Loxapine in Agitated Patients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721955).
- Staccato Prochlorperazine in Migraine (Out Patient): Complete Statistical AnalysisIndependent statistical analysis of Staccato Prochlorperazine in Migraine (Out Patient): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00422812).
- STAGEIndependent statistical analysis of A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- STAGEIndependent statistical analysis of STorz Against Glidescope Effectiveness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632683).
- STAMPVAIndependent statistical analysis of Sharing and Talking About my Preferences: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03103828).
- STANDIndependent statistical analysis of Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Stand if You Can: A Standing Intervention in Long Term Care: Complete Statistical AnalysisIndependent statistical analysis of Stand if You Can: A Standing Intervention in Long Term Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Standard Colonoscopy Versus Colonoscopy With Endocuff Vision: Complete Statistical AnalysisIndependent statistical analysis of Standard Colonoscopy Versus Colonoscopy With Endocuff Vision: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03361917).
- Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004: Complete Statistical AnalysisIndependent statistical analysis of Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004: primary endpoint results, effect estimate with confidence…
- Standardization of Surgery on the Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Standardization of Surgery on the Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00679913).
- STARIndependent statistical analysis of Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- STARIndependent statistical analysis of Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- STAR Cape+BKM120 MBC With Brain Met: Complete Statistical AnalysisIndependent statistical analysis of STAR Cape+BKM120 MBC With Brain Met: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02000882).
- STAR-OMIndependent statistical analysis of Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- STARDUSTIndependent statistical analysis of Liraglutide and Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04881110).
- STARR-NCIndependent statistical analysis of Supporting Tailored And Responsive PrEP in Rural North Carolina: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05984030).